Aurora BioScience Medical Devices Critical Care Clinical Indications Intravascular Temperature Management

Aurora BioScience Critical Care

Alisus^® Intravascular Temperature Management Current Clinical Indications

Reduction of Fever in the Neuro ICU:
Neurointensive care clinicians aggressively attempt to reduce fever in patients with severe neuronal injury including those who have suffered intracerebral hemorrhage, subarrachnoid hemorrhage, ischemic stroke and traumatic brain injury. Current techniques of antipyretic therapy and surface cooling have limited effects and are labour intensive. Alsius® studied the Cool Line / CoolGuard 3000® system in 296 Neuro ICU patients. The Alsius® technology reduced fever by 64% when used as an adjunct to conventional fever management techniques.

Aneurysm Surgery:
Recent clinical trials have shown an improve neurological benefit and improved discharge status in patients who had been cooled to 32-34°C during surgical clipping of ruptured cerebral aneurysms. Alsius® catheters provide a powerful solution to improved cooling/rewarm during neurosurgical aneurysm repair.

Emerging Applications:
Hypothermia therapy shows great promise in improving outcome for Neuro ICU patients that have suffered traumatic brain injury and stroke. Alsius® is currently supporting several investigations using the Icy Catheter to induce and reverse hypothermia in these patient populations.

Cardiac Arrest:
The use of hypothermia therapy has been shown in recent studies to reduce mortality and improve long-term neurological deficit in patients who have suffered cardiac arrest. The International Liaison Committee on Resuscitation (ILCOR) has included the use of therapeutic hypothermia as a Level 1 guideline.

Alsius Corporation is sponsoring the CoolHeart Registry with the European Resuscitation Council to examine clinical practice patterns using the Icy Catheter to induce hypothermia therapy in patients who have been resuscitated from cardiac arrest. To learn more about the CoolHeart Registry, please click here.

Critical Care - Intravascular Temperature Management

Commercialisation Agency Strategic Marketing Consultancy News & Events

Aurora BioScience Critical Care

Home About Aurora BioScience Our Mission Our Company Profile Our Expertise Medical Conferences Healthcare Professionals Contact Us Community Links Search Site Map	Aurora BioScience Critical Care Alisus^® Intravascular Temperature Management Current Clinical Indications Neuro Reduction of Fever in the Neuro ICU: Neurointensive care clinicians aggressively attempt to reduce fever in patients with severe neuronal injury including those who have suffered intracerebral hemorrhage, subarrachnoid hemorrhage, ischemic stroke and traumatic brain injury. Current techniques of antipyretic therapy and surface cooling have limited effects and are labour intensive. Alsius® studied the Cool Line / CoolGuard 3000® system in 296 Neuro ICU patients. The Alsius® technology reduced fever by 64% when used as an adjunct to conventional fever management techniques. Aneurysm Surgery: Recent clinical trials have shown an improve neurological benefit and improved discharge status in patients who had been cooled to 32-34°C during surgical clipping of ruptured cerebral aneurysms. Alsius® catheters provide a powerful solution to improved cooling/rewarm during neurosurgical aneurysm repair. Emerging Applications: Hypothermia therapy shows great promise in improving outcome for Neuro ICU patients that have suffered traumatic brain injury and stroke. Alsius® is currently supporting several investigations using the Icy Catheter to induce and reverse hypothermia in these patient populations. Cardiac Cardiac Arrest: The use of hypothermia therapy has been shown in recent studies to reduce mortality and improve long-term neurological deficit in patients who have suffered cardiac arrest. The International Liaison Committee on Resuscitation (ILCOR) has included the use of therapeutic hypothermia as a Level 1 guideline. Alsius Corporation is sponsoring the CoolHeart Registry with the European Resuscitation Council to examine clinical practice patterns using the Icy Catheter to induce hypothermia therapy in patients who have been resuscitated from cardiac arrest. To learn more about the CoolHeart Registry, please click here. TOP	Products
Last Updated : 15 Mar 2007
Privacy Policy Disclaimer Terms & Conditions Home ©2005-07 Aurora BioScience Pty Ltd